Raymond James & Associates’s iShares Emerging Markets Dividend ETF DVYE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $452K | Sell |
15,744
-31
| -0.2% | -$846 | ﹤0.01% | 3169 |
|
|
2024
Q2 | $429K | Buy |
15,775
+264
| +2% | +$7.28K | ﹤0.01% | 3162 |
|
|
2024
Q1 | $406K | Sell |
15,511
-122
| -0.8% | -$3.2K | ﹤0.01% | 3196 |
|
|
2023
Q4 | $414K | Buy |
15,633
+5,024
| +47% | +$125K | ﹤0.01% | 3070 |
|
|
2023
Q3 | $253K | Hold |
10,609
| – | – | ﹤0.01% | 3322 |
|
|
2023
Q2 | $260K | Buy |
10,609
+76
| +0.7% | +$1.88K | ﹤0.01% | 3342 |
|
|
2023
Q1 | $258K | Sell |
10,533
-878
| -8% | -$21.9K | ﹤0.01% | 3338 |
|
|
2022
Q4 | $275K | Buy |
11,411
+824
| +8% | +$19.7K | ﹤0.01% | 3273 |
|
|
2022
Q3 | $240K | Buy |
+10,587
| New | +$270K | ﹤0.01% | 3319 |
|
|
2022
Q2 | – | Sell |
-6,809
| Closed | -$223K | – | 4068 |
|
|
2022
Q1 | $223K | Buy |
6,809
+1,522
| +29% | +$55.4K | ﹤0.01% | 3607 |
|
|
2021
Q4 | $204K | Buy |
5,287
+43
| +0.8% | +$1.66K | ﹤0.01% | 3691 |
|
|
2021
Q3 | $204K | Sell |
5,244
-287
| -5% | -$11.1K | ﹤0.01% | 3656 |
|
|
2021
Q2 | $215K | Sell |
5,531
-1,901
| -26% | -$75.8K | ﹤0.01% | 3643 |
|
|
2021
Q1 | $291K | Buy |
7,432
+135
| +2% | +$5.21K | ﹤0.01% | 3377 |
|
|
2020
Q4 | $272K | Sell |
7,297
-18,960
| -72% | -$635K | ﹤0.01% | 3183 |
|
|
2020
Q3 | $791K | Sell |
26,257
-2,055
| -7% | -$65.6K | ﹤0.01% | 2318 |
|
|
2020
Q2 | $887K | Sell |
28,312
-3,557
| -11% | -$110K | ﹤0.01% | 2244 |
|
|
2020
Q1 | $897K | Sell |
31,869
-36,783
| -54% | -$1.34M | ﹤0.01% | 2058 |
|
|
2019
Q4 | $2.79M | Sell |
68,652
-64,738
| -49% | -$2.5M | ﹤0.01% | 1622 |
|
|
2019
Q3 | $4.99M | Sell |
133,390
-6,396
| -5% | -$251K | 0.01% | 1228 |
|
|
2019
Q2 | $5.7M | Sell |
139,786
-1,790
| -1% | -$71.7K | 0.01% | 1145 |
|
|
2019
Q1 | $5.69M | Buy |
141,576
+113,446
| +403% | +$4.59M | 0.01% | 1121 |
|
|
2018
Q4 | $1.05M | Buy |
28,130
+5,038
| +22% | +$192K | ﹤0.01% | 2058 |
|
|
2018
Q3 | $898K | Sell |
23,092
-113,884
| -83% | -$4.52M | ﹤0.01% | 2319 |
|
|
2018
Q2 | $5.39M | Buy |
136,976
+8,214
| +6% | +$340K | 0.01% | 1152 |
|
|
2018
Q1 | $5.58M | Buy |
128,762
+13,377
| +12% | +$586K | 0.01% | 1091 |
|
|
2017
Q4 | $4.83M | Buy |
115,385
+3,886
| +3% | +$161K | 0.01% | 1145 |
|
|
2017
Q3 | $4.62M | Buy |
111,499
+79,426
| +248% | +$3.33M | 0.01% | 1125 |
|
|
2017
Q2 | $1.29M | Buy |
32,073
+10,457
| +48% | +$421K | ﹤0.01% | 1859 |
|
|
2017
Q1 | $861K | Sell |
21,616
-1,425
| -6% | -$54.5K | ﹤0.01% | 2068 |
|
|
2016
Q4 | $797K | Sell |
23,041
-187,690
| -89% | -$6.57M | ﹤0.01% | 2065 |
|
|
2016
Q3 | $7.57M | Buy |
210,731
+129,557
| +160% | +$4.63M | 0.02% | 736 |
|
|
2016
Q2 | $2.71M | Buy |
+81,174
| New | +$2.64M | 0.01% | 1158 |
|
Other funds holding DVYE
AOI
OMC
RWM
Raymond James & Associates's DVYE Position: Q3 2024 in Review
Raymond James & Associates reduced its iShares Emerging Markets Dividend ETF (DVYE) stake by 0.2% in Q3 2024, selling an estimated $846 and leaving 15,744 shares worth $452K. The position accounts for ﹤0.01% of the portfolio, ranked #3169.
Raymond James & Associates first reported a position in DVYE in Q2 2016 and has held it in 33 quarters since. The position peaked at $7.57M in Q3 2016. 148 funds tracked by Wall St. Rank hold DVYE as of Q3 2024.
- Raymond James & Associates held 15,744 shares of iShares Emerging Markets Dividend ETF worth $452K as of Q3 2024.
- Raymond James & Associates sold 31 iShares Emerging Markets Dividend ETF shares in Q3 2024, an estimated $846.
- iShares Emerging Markets Dividend ETF made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3169 holding.
- Raymond James & Associates first reported a position in iShares Emerging Markets Dividend ETF in Q2 2016 and has held it in 33 quarters since.
- Raymond James & Associates's iShares Emerging Markets Dividend ETF position peaked at $7.57M in Q3 2016.
- 148 funds tracked by Wall St. Rank held iShares Emerging Markets Dividend ETF as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.